Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
JAMA Health Forum. 2021 Dec 23;2(12):e214223. doi: 10.1001/jamahealthforum.2021.4223. eCollection 2021 Dec.
The COVID-19 pandemic has disproportionately affected racial and ethnic minority populations. However, racial and ethnic disparities in hospitalization outcomes during the pandemic-for both COVID-19 and non-COVID-19 hospitalizations-are poorly understood, especially among older populations.
To assess racial and ethnic differences in hospitalization outcomes during the COVID-19 pandemic among Medicare beneficiaries.
In the 100% traditional Medicare inpatient data, there were 31 771 054 unique beneficiaries in cross-section just before the pandemic (February 2020), among whom 26 225 623 were non-Hispanic White, 2 797 462 were Black, 692 994 were Hispanic, and 2 054 975 belonged to other racial and ethnic minority groups. There were 14 021 285 hospitalizations from January 2019 through February 2021, of which 11 353 581 were among non-Hispanic White beneficiaries, 1 656 856 among Black beneficiaries, 321 090 among Hispanic beneficiaries, and 689 758 among beneficiaries of other racial and ethnic minority groups. Sensitivity analyses tested expanded definitions of mortality and alternative model specifications.
Race and ethnicity in Medicare claims from the Social Security Administration.
In-hospital mortality and mortality inclusive of discharges to hospice, deaths during 30-day readmissions, and 30-day all-cause mortality. Secondary outcomes included discharges to hospice and discharges to postacute care.
The decline in non-COVID-19 and emergence of COVID-19 hospitalizations were qualitatively similar among beneficiaries of different racial and ethnic minority groups through February 2021. In-hospital COVID-19 mortality was not significantly different among Black patients relative to White patients, but was 3.5 percentage points higher among Hispanic patients (95% CI, 2.9-4.1; < .001) and other racial and ethnic minority patients relative to White counterparts (95% CI, 3.0-4.1; < .001). For non-COVID-19 hospitalizations, in-hospital mortality among Black patients increased by 0.5 percentage points more than it increased among White patients (95% CI, 0.3-0.6; < .001), a 17.5% differential increase relative to the prepandemic baseline. This gap was robust to expanded definitions of mortality. Hispanic patients had similar differential increases in expanded definitions of mortality and model specification. Disparities in discharges to hospice and postacute care were evident. In aggregate across COVID-19 and non-COVID-19 hospitalizations, mortality differentially increased among racial and ethnic minority populations during the pandemic.
In this cohort study, racial and ethnic disparities in mortality were evident among COVID-19 hospitalizations and widened among non-COVID-19 hospitalizations, motivating greater attention to health equity.
COVID-19 大流行对种族和族裔少数群体的影响不成比例。然而,人们对大流行期间住院结果的种族和族裔差异(包括 COVID-19 和非 COVID-19 住院)知之甚少,尤其是在老年人群中。
评估医疗保险受益人群在 COVID-19 大流行期间 COVID-19 住院治疗的住院结果中的种族和族裔差异。
设计、设置和参与者:在传统医疗保险的 100%住院患者数据中,在大流行前(2020 年 2 月)有 31771054 名独特的受益人群,其中 26225623 名是非西班牙裔白人,2797462 名是黑人,692994 名是西班牙裔,2054975 名属于其他种族和族裔少数群体。从 2019 年 1 月至 2021 年 2 月,有 14021285 例住院治疗,其中 11353581 例是在非西班牙裔白人受益人群中,1656856 例是在黑人受益人群中,321090 例是在西班牙裔受益人群中,689758 例是在其他种族和族裔少数群体受益人群中。敏感性分析测试了死亡率的扩展定义和替代模型规范。
医疗保险索赔中的种族和族裔,来自社会保障管理局。
住院死亡率和包括临终关怀出院在内的死亡率、30 天内再入院死亡率和 30 天全因死亡率。次要结果包括临终关怀出院和急性后护理出院。
通过 2021 年 2 月,不同种族和族裔少数群体受益人群的非 COVID-19 和 COVID-19 住院治疗的下降趋势相似。与白人患者相比,黑人患者的 COVID-19 住院死亡率没有显著差异,但与西班牙裔患者(95%CI,2.9-4.1; < .001)和其他种族和族裔少数患者(95%CI,3.0-4.1; < .001)相比,死亡率高出 3.5 个百分点。对于非 COVID-19 住院治疗,与白人患者相比,黑人患者的住院死亡率增加了 0.5 个百分点(95%CI,0.3-0.6; < .001),与大流行前基线相比,增加了 17.5%。这种差距在扩大的死亡率定义中是稳健的。西班牙裔患者在扩大的死亡率定义和模型规范中也有类似的差异增加。临终关怀和急性后护理的出院差异明显。总体而言,在 COVID-19 和非 COVID-19 住院治疗中,在大流行期间,少数民族的死亡率差异明显增加。
在这项队列研究中,COVID-19 住院治疗中存在明显的种族和族裔差异,而非 COVID-19 住院治疗中的差异扩大,这促使人们更加关注健康公平。